Haga Bioscience Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.24M
- Investors
-
4
Haga Bioscience General Information
Description
Developer of genetic spatial analysis technologies intended to visualize genes and mutations as biomarkers within intact tissue at single-cell resolution. The company develops high-throughput spatial genomics tools and analytics, enabling researchers to advance disease understanding and uncover new therapeutic targets.
Contact Information
Website
hagabioscience.comCorporate Office
- Nobels väg 16
- 171 65 Solna
- Sweden
Corporate Office
- Nobels väg 16
- 171 65 Solna
- Sweden
Haga Bioscience Timeline
Haga Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 04-Jun-2026 | $2.24M | Completed | Startup | ||
| 2. Early Stage VC | 01-Jan-2025 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Stealth |
Haga Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Haga Bioscience Patents
Haga Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4698678-A1 | A method for profiling of mutations via gap filling on rna and a kit for use in a method for profiling of mutations | Pending | 17-Apr-2023 | ||
| US-20260286430-A1 | A method for profiling of mutations via gap filling on rna and a kit for use in a method for profiling of mutations | Pending | 17-Apr-2023 | ||
| EP-4658811-A1 | A method for in-situ profiling of single nucleotide variations in an rna sample and a kit for use in in-situ profiling of single nucleotide variations in an rna sample | Pending | 02-Feb-2023 | ||
| US-20260234704-A1 | A method for in-situ profiling of single nucleotide variations in an rna sample and a kit for use in in-situ profiling of single nucleotide variations in an rna sample | Pending | 02-Feb-2023 | C12Q1/6841 |
Haga Bioscience Signals
Haga Bioscience Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Almi Invest | Venture Capital | Minority | ||
| Life Science Invest | Angel Group | Minority | ||
| SU Holding | Venture Capital | Minority | ||
| DRIVE (KI Innovations Business Incubator) | Accelerator/Incubator |
Haga Bioscience FAQs
-
When was Haga Bioscience founded?
Haga Bioscience was founded in 2024.
-
Where is Haga Bioscience headquartered?
Haga Bioscience is headquartered in Solna, Sweden.
-
What is the size of Haga Bioscience?
Haga Bioscience has 8 total employees.
-
What industry is Haga Bioscience in?
Haga Bioscience’s primary industry is Discovery Tools (Healthcare).
-
Is Haga Bioscience a private or public company?
Haga Bioscience is a Private company.
-
What is Haga Bioscience’s current revenue?
The current revenue for Haga Bioscience is .
-
How much funding has Haga Bioscience raised over time?
Haga Bioscience has raised $2.86M.
-
Who are Haga Bioscience’s investors?
Almi Invest, Life Science Invest, SU Holding, and DRIVE (KI Innovations Business Incubator) have invested in Haga Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process